Meyer A A, Manktelow A, Johnson M, deSerres S, Herzog S, Peterson H D
University of North Carolina, Chapel Hill 27514.
J Trauma. 1988 Jul;28(7):1054-9. doi: 10.1097/00005373-198807000-00023.
Cultured keratinocytes (CK) have been used to resurface large burn wounds with some success. These CK are grown in the presence of fetal bovine serum (FBS) and mouse fibroblasts (MF). Serum from ten patients who received CK grafts as part of burn wound coverage was studied by ELISA technique for antibody to these xenogeneic antigens. All patients had some amount of antibody to FBS but no detectable antibody to MF. The amount of antibody to FBS varied between patients and with respect to time after graft application. Generally, the levels of antibody to FBS were moderate by 30 days, declined, and then rose slowly by 5 to 6 months. The majority of antibody to FBS was against bovine serum albumin (BSA), demonstrated by Western blot technique. The presence of such antibody to FBS might produce clinical problems of graft rejection, anaphylaxis, and serum sickness in patients receiving CK grown in FBS supplemental medium. Further investigation will need to determine the likelihood and potential severity of such clinical problems.
培养的角质形成细胞(CK)已被用于大面积烧伤创面的皮肤移植,并取得了一定成功。这些CK在胎牛血清(FBS)和小鼠成纤维细胞(MF)存在的情况下生长。采用ELISA技术研究了10例接受CK移植作为烧伤创面覆盖一部分患者的血清中针对这些异种抗原的抗体。所有患者均有一定量的抗FBS抗体,但未检测到抗MF抗体。患者之间以及移植后不同时间的抗FBS抗体量有所不同。一般来说,抗FBS抗体水平在30天时为中等,随后下降,然后在5至6个月时缓慢上升。通过蛋白质免疫印迹技术证实,大多数抗FBS抗体针对牛血清白蛋白(BSA)。在接受在添加FBS的培养基中培养的CK的患者中,这种抗FBS抗体的存在可能会产生移植排斥、过敏反应和血清病等临床问题。进一步的研究将需要确定此类临床问题的可能性和潜在严重程度。